nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0727	0.147	CbGbCtD
Vinorelbine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0727	0.147	CbGbCtD
Vinorelbine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0648	0.131	CbGbCtD
Vinorelbine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.061	0.124	CbGbCtD
Vinorelbine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0412	0.0835	CbGbCtD
Vinorelbine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0393	0.0797	CbGbCtD
Vinorelbine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.035	0.071	CbGbCtD
Vinorelbine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0343	0.0695	CbGbCtD
Vinorelbine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0324	0.0657	CbGbCtD
Vinorelbine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0205	0.0417	CbGbCtD
Vinorelbine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0194	0.0393	CbGbCtD
Vinorelbine—TUBB3—respiratory system—chronic obstructive pulmonary disease	0.00641	0.0659	CbGeAlD
Vinorelbine—TUBB3—connective tissue—chronic obstructive pulmonary disease	0.00565	0.058	CbGeAlD
Vinorelbine—TUBB8—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00494	0.0682	CbGpPWpGaD
Vinorelbine—TUBB4A—respiratory system—chronic obstructive pulmonary disease	0.0039	0.0401	CbGeAlD
Vinorelbine—TUBB2B—respiratory system—chronic obstructive pulmonary disease	0.00377	0.0387	CbGeAlD
Vinorelbine—TUBB2A—respiratory system—chronic obstructive pulmonary disease	0.00355	0.0365	CbGeAlD
Vinorelbine—TUBB6—respiratory system—chronic obstructive pulmonary disease	0.0035	0.036	CbGeAlD
Vinorelbine—TUBB4A—connective tissue—chronic obstructive pulmonary disease	0.00344	0.0353	CbGeAlD
Vinorelbine—TUBB3—lung—chronic obstructive pulmonary disease	0.00341	0.035	CbGeAlD
Vinorelbine—TUBB2B—connective tissue—chronic obstructive pulmonary disease	0.00332	0.0341	CbGeAlD
Vinorelbine—TUBB2A—connective tissue—chronic obstructive pulmonary disease	0.00313	0.0321	CbGeAlD
Vinorelbine—TUBB2B—bronchus—chronic obstructive pulmonary disease	0.0031	0.0319	CbGeAlD
Vinorelbine—TUBB4B—respiratory system—chronic obstructive pulmonary disease	0.00304	0.0313	CbGeAlD
Vinorelbine—TUBB—bronchus—chronic obstructive pulmonary disease	0.00294	0.0302	CbGeAlD
Vinorelbine—TUBB2A—bronchus—chronic obstructive pulmonary disease	0.00292	0.03	CbGeAlD
Vinorelbine—TUBB6—bronchus—chronic obstructive pulmonary disease	0.00288	0.0296	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00287	0.0295	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00286	0.0294	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—chronic obstructive pulmonary disease	0.00282	0.029	CbGeAlD
Vinorelbine—TUBB2B—trachea—chronic obstructive pulmonary disease	0.00279	0.0286	CbGeAlD
Vinorelbine—TUBB4B—connective tissue—chronic obstructive pulmonary disease	0.00268	0.0275	CbGeAlD
Vinorelbine—TUBB—trachea—chronic obstructive pulmonary disease	0.00264	0.0271	CbGeAlD
Vinorelbine—TUBB2A—trachea—chronic obstructive pulmonary disease	0.00262	0.0269	CbGeAlD
Vinorelbine—TUBB6—trachea—chronic obstructive pulmonary disease	0.00259	0.0266	CbGeAlD
Vinorelbine—TUBB4B—bronchus—chronic obstructive pulmonary disease	0.00251	0.0257	CbGeAlD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.0025	0.0345	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.0025	0.0345	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00248	0.0342	CbGpPWpGaD
Vinorelbine—TUBB4B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00245	0.0252	CbGeAlD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00241	0.0333	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00234	0.0322	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00229	0.0315	CbGpPWpGaD
Vinorelbine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00226	0.0312	CbGpPWpGaD
Vinorelbine—TUBB4B—trachea—chronic obstructive pulmonary disease	0.00225	0.0231	CbGeAlD
Vinorelbine—TUBB4A—lung—chronic obstructive pulmonary disease	0.00207	0.0213	CbGeAlD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00205	0.0283	CbGpPWpGaD
Vinorelbine—TUBB2B—lung—chronic obstructive pulmonary disease	0.002	0.0206	CbGeAlD
Vinorelbine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.002	0.0276	CbGpPWpGaD
Vinorelbine—TUBB—lung—chronic obstructive pulmonary disease	0.0019	0.0195	CbGeAlD
Vinorelbine—TUBB2A—lung—chronic obstructive pulmonary disease	0.00189	0.0194	CbGeAlD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00188	0.0259	CbGpPWpGaD
Vinorelbine—TUBB6—lung—chronic obstructive pulmonary disease	0.00186	0.0191	CbGeAlD
Vinorelbine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00164	0.0226	CbGpPWpGaD
Vinorelbine—TUBB4B—lung—chronic obstructive pulmonary disease	0.00162	0.0166	CbGeAlD
Vinorelbine—TUBB8—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.00139	0.0191	CbGpPWpGaD
Vinorelbine—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—GSTP1—chronic obstructive pulmonary disease	0.00102	0.0141	CbGpPWpGaD
Vinorelbine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000885	0.00909	CbGeAlD
Vinorelbine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00083	0.0115	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000701	0.00967	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000701	0.00967	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000698	0.00963	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000698	0.00963	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000695	0.00958	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000677	0.00934	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000674	0.0093	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000656	0.00905	CbGpPWpGaD
Vinorelbine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000655	0.00904	CbGpPWpGaD
Vinorelbine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000654	0.00672	CbGeAlD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000653	0.009	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000641	0.00884	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000638	0.0088	CbGpPWpGaD
Vinorelbine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000636	0.00878	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000622	0.00858	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000622	0.00858	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000601	0.00829	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000582	0.00802	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000576	0.00794	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000573	0.0079	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000569	0.00785	CbGpPWpGaD
Vinorelbine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000564	0.00167	CcSEcCtD
Vinorelbine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00165	CcSEcCtD
Vinorelbine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00165	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000552	0.00164	CcSEcCtD
Vinorelbine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00164	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.00163	CcSEcCtD
Vinorelbine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00163	CcSEcCtD
Vinorelbine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00163	CcSEcCtD
Vinorelbine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000548	0.00756	CbGpPWpGaD
Vinorelbine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000545	0.00162	CcSEcCtD
Vinorelbine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000545	0.00162	CcSEcCtD
Vinorelbine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00161	CcSEcCtD
Vinorelbine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00161	CcSEcCtD
Vinorelbine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00161	CcSEcCtD
Vinorelbine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000541	0.00161	CcSEcCtD
Vinorelbine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000538	0.0016	CcSEcCtD
Vinorelbine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00159	CcSEcCtD
Vinorelbine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.00158	CcSEcCtD
Vinorelbine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000534	0.00158	CcSEcCtD
Vinorelbine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000534	0.00158	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00158	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00158	CcSEcCtD
Vinorelbine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00157	CcSEcCtD
Vinorelbine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00157	CcSEcCtD
Vinorelbine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.00727	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000527	0.00726	CbGpPWpGaD
Vinorelbine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00156	CcSEcCtD
Vinorelbine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00156	CcSEcCtD
Vinorelbine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00156	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000524	0.00723	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000522	0.00155	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.00154	CcSEcCtD
Vinorelbine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00154	CcSEcCtD
Vinorelbine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000518	0.00154	CcSEcCtD
Vinorelbine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00152	CcSEcCtD
Vinorelbine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00152	CcSEcCtD
Vinorelbine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00152	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000511	0.00705	CbGpPWpGaD
Vinorelbine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00151	CcSEcCtD
Vinorelbine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00151	CcSEcCtD
Vinorelbine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.0015	CcSEcCtD
Vinorelbine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.0015	CcSEcCtD
Vinorelbine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.0015	CcSEcCtD
Vinorelbine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000506	0.0015	CcSEcCtD
Vinorelbine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000505	0.0015	CcSEcCtD
Vinorelbine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.0015	CcSEcCtD
Vinorelbine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000504	0.0015	CcSEcCtD
Vinorelbine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000503	0.00149	CcSEcCtD
Vinorelbine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00149	CcSEcCtD
Vinorelbine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.00149	CcSEcCtD
Vinorelbine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000502	0.00149	CcSEcCtD
Vinorelbine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00148	CcSEcCtD
Vinorelbine—Infection—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00148	CcSEcCtD
Vinorelbine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.00148	CcSEcCtD
Vinorelbine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00148	CcSEcCtD
Vinorelbine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00148	CcSEcCtD
Vinorelbine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000498	0.00148	CcSEcCtD
Vinorelbine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00146	CcSEcCtD
Vinorelbine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000493	0.0068	CbGpPWpGaD
Vinorelbine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000493	0.00146	CcSEcCtD
Vinorelbine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000492	0.00146	CcSEcCtD
Vinorelbine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00145	CcSEcCtD
Vinorelbine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00144	CcSEcCtD
Vinorelbine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00143	CcSEcCtD
Vinorelbine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00142	CcSEcCtD
Vinorelbine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00142	CcSEcCtD
Vinorelbine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00048	0.00142	CcSEcCtD
Vinorelbine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00142	CcSEcCtD
Vinorelbine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000476	0.00657	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00141	CcSEcCtD
Vinorelbine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000475	0.00141	CcSEcCtD
Vinorelbine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00141	CcSEcCtD
Vinorelbine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.0014	CcSEcCtD
Vinorelbine—ABCB1—lung—chronic obstructive pulmonary disease	0.00047	0.00483	CbGeAlD
Vinorelbine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000469	0.00139	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00139	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00139	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000467	0.00644	CbGpPWpGaD
Vinorelbine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.00137	CcSEcCtD
Vinorelbine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000462	0.00137	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000459	0.00136	CcSEcCtD
Vinorelbine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00136	CcSEcCtD
Vinorelbine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00136	CcSEcCtD
Vinorelbine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00135	CcSEcCtD
Vinorelbine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00134	CcSEcCtD
Vinorelbine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00134	CcSEcCtD
Vinorelbine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00132	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00132	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00132	CcSEcCtD
Vinorelbine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00131	CcSEcCtD
Vinorelbine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00131	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00131	CcSEcCtD
Vinorelbine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00044	0.0013	CcSEcCtD
Vinorelbine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00044	0.0013	CcSEcCtD
Vinorelbine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.0013	CcSEcCtD
Vinorelbine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.0013	CcSEcCtD
Vinorelbine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00129	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00129	CcSEcCtD
Vinorelbine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00129	CcSEcCtD
Vinorelbine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00128	CcSEcCtD
Vinorelbine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000431	0.00128	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00043	0.00128	CcSEcCtD
Vinorelbine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000429	0.00127	CcSEcCtD
Vinorelbine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000429	0.00591	CbGpPWpGaD
Vinorelbine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00127	CcSEcCtD
Vinorelbine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00127	CcSEcCtD
Vinorelbine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000426	0.00126	CcSEcCtD
Vinorelbine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000425	0.00126	CcSEcCtD
Vinorelbine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00126	CcSEcCtD
Vinorelbine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00126	CcSEcCtD
Vinorelbine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.00126	CcSEcCtD
Vinorelbine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00125	CcSEcCtD
Vinorelbine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00125	CcSEcCtD
Vinorelbine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.00125	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00125	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00125	CcSEcCtD
Vinorelbine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00125	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00124	CcSEcCtD
Vinorelbine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00124	CcSEcCtD
Vinorelbine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00123	CcSEcCtD
Vinorelbine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00123	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00122	CcSEcCtD
Vinorelbine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00121	CcSEcCtD
Vinorelbine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00121	CcSEcCtD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000407	0.00562	CbGpPWpGaD
Vinorelbine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00121	CcSEcCtD
Vinorelbine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00121	CcSEcCtD
Vinorelbine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00121	CcSEcCtD
Vinorelbine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00121	CcSEcCtD
Vinorelbine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.0012	CcSEcCtD
Vinorelbine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000402	0.00119	CcSEcCtD
Vinorelbine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000401	0.00119	CcSEcCtD
Vinorelbine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000401	0.00119	CcSEcCtD
Vinorelbine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00119	CcSEcCtD
Vinorelbine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00119	CcSEcCtD
Vinorelbine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00118	CcSEcCtD
Vinorelbine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000398	0.00549	CbGpPWpGaD
Vinorelbine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00118	CcSEcCtD
Vinorelbine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00118	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00118	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000392	0.0054	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000392	0.0054	CbGpPWpGaD
Vinorelbine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00039	0.00538	CbGpPWpGaD
Vinorelbine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00114	CcSEcCtD
Vinorelbine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00114	CcSEcCtD
Vinorelbine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00114	CcSEcCtD
Vinorelbine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.00528	CbGpPWpGaD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.00525	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00112	CcSEcCtD
Vinorelbine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00112	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000378	0.00522	CbGpPWpGaD
Vinorelbine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000378	0.00112	CcSEcCtD
Vinorelbine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000373	0.00515	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000371	0.0011	CcSEcCtD
Vinorelbine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00109	CcSEcCtD
Vinorelbine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00109	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000366	0.00505	CbGpPWpGaD
Vinorelbine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00108	CcSEcCtD
Vinorelbine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00108	CcSEcCtD
Vinorelbine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00108	CcSEcCtD
Vinorelbine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00107	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—chronic obstructive pulmonary disease	0.000359	0.00496	CbGpPWpGaD
Vinorelbine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000358	0.00494	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000358	0.00494	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00106	CcSEcCtD
Vinorelbine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00106	CcSEcCtD
Vinorelbine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00104	CcSEcCtD
Vinorelbine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00104	CcSEcCtD
Vinorelbine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00104	CcSEcCtD
Vinorelbine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00103	CcSEcCtD
Vinorelbine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00103	CcSEcCtD
Vinorelbine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000345	0.00475	CbGpPWpGaD
Vinorelbine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00102	CcSEcCtD
Vinorelbine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00102	CcSEcCtD
Vinorelbine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.00101	CcSEcCtD
Vinorelbine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00101	CcSEcCtD
Vinorelbine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00101	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000333	0.00459	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000333	0.00459	CbGpPWpGaD
Vinorelbine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000333	0.000988	CcSEcCtD
Vinorelbine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000987	CcSEcCtD
Vinorelbine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.000985	CcSEcCtD
Vinorelbine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.000969	CcSEcCtD
Vinorelbine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000327	0.000969	CcSEcCtD
Vinorelbine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000324	0.000961	CcSEcCtD
Vinorelbine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.000961	CcSEcCtD
Vinorelbine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000324	0.000961	CcSEcCtD
Vinorelbine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.000961	CcSEcCtD
Vinorelbine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000322	0.000955	CcSEcCtD
Vinorelbine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.000955	CcSEcCtD
Vinorelbine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000955	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000322	0.00444	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000322	0.00444	CbGpPWpGaD
Vinorelbine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.000952	CcSEcCtD
Vinorelbine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00095	CcSEcCtD
Vinorelbine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000317	0.000942	CcSEcCtD
Vinorelbine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000317	0.000941	CcSEcCtD
Vinorelbine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.000939	CcSEcCtD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000316	0.00436	CbGpPWpGaD
Vinorelbine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000315	0.000936	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000313	0.000927	CcSEcCtD
Vinorelbine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.000925	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000312	0.0043	CbGpPWpGaD
Vinorelbine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000311	0.00429	CbGpPWpGaD
Vinorelbine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000922	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000922	CcSEcCtD
Vinorelbine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.000915	CcSEcCtD
Vinorelbine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.000912	CcSEcCtD
Vinorelbine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.000909	CcSEcCtD
Vinorelbine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.000908	CcSEcCtD
Vinorelbine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.000907	CcSEcCtD
Vinorelbine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.000906	CcSEcCtD
Vinorelbine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000305	0.000906	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000305	0.0042	CbGpPWpGaD
Vinorelbine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.000902	CcSEcCtD
Vinorelbine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000299	0.000887	CcSEcCtD
Vinorelbine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000299	0.00412	CbGpPWpGaD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000296	0.00408	CbGpPWpGaD
Vinorelbine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.000874	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000294	0.00406	CbGpPWpGaD
Vinorelbine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000855	CcSEcCtD
Vinorelbine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.000851	CcSEcCtD
Vinorelbine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00391	CbGpPWpGaD
Vinorelbine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00083	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000826	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000274	0.00377	CbGpPWpGaD
Vinorelbine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.000806	CcSEcCtD
Vinorelbine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000784	CcSEcCtD
Vinorelbine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00359	CbGpPWpGaD
Vinorelbine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000766	CcSEcCtD
Vinorelbine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000763	CcSEcCtD
Vinorelbine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000755	CcSEcCtD
Vinorelbine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000746	CcSEcCtD
Vinorelbine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00025	0.00345	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00025	0.00345	CbGpPWpGaD
Vinorelbine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.000742	CcSEcCtD
Vinorelbine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000735	CcSEcCtD
Vinorelbine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000735	CcSEcCtD
Vinorelbine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000706	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000238	0.00328	CbGpPWpGaD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.00323	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000233	0.00321	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000682	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00068	CcSEcCtD
Vinorelbine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00068	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000228	0.00314	CbGpPWpGaD
Vinorelbine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000672	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000225	0.0031	CbGpPWpGaD
Vinorelbine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000663	CcSEcCtD
Vinorelbine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000661	CcSEcCtD
Vinorelbine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000656	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000219	0.00302	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000217	0.00299	CbGpPWpGaD
Vinorelbine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000635	CcSEcCtD
Vinorelbine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000626	CcSEcCtD
Vinorelbine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000626	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000622	CcSEcCtD
Vinorelbine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000618	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000608	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000202	0.0006	CcSEcCtD
Vinorelbine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000596	CcSEcCtD
Vinorelbine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000588	CcSEcCtD
Vinorelbine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000586	CcSEcCtD
Vinorelbine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000583	CcSEcCtD
Vinorelbine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000572	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00255	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000547	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000184	0.00254	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.00254	CbGpPWpGaD
Vinorelbine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000546	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000539	CcSEcCtD
Vinorelbine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000522	CcSEcCtD
Vinorelbine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000521	CcSEcCtD
Vinorelbine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00052	CcSEcCtD
Vinorelbine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000517	CcSEcCtD
Vinorelbine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000517	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000174	0.00239	CbGpPWpGaD
Vinorelbine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000513	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000494	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00228	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000491	CcSEcCtD
Vinorelbine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000491	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00225	CbGpPWpGaD
Vinorelbine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000477	CcSEcCtD
Vinorelbine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000474	CcSEcCtD
Vinorelbine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000474	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000159	0.0022	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000154	0.00212	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000154	0.00212	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000152	0.0021	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000442	CcSEcCtD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00205	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000149	0.00205	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000148	0.00205	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00203	CbGpPWpGaD
Vinorelbine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000431	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000144	0.00198	CbGpPWpGaD
Vinorelbine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000425	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000142	0.00196	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000141	0.00195	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.00014	0.00194	CbGpPWpGaD
Vinorelbine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000411	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000138	0.0019	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000138	0.0019	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00189	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00189	CbGpPWpGaD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00185	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00185	CbGpPWpGaD
Vinorelbine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000397	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000133	0.00184	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000132	0.00182	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000132	0.00181	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000129	0.00178	CbGpPWpGaD
Vinorelbine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000382	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000128	0.00177	CbGpPWpGaD
Vinorelbine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000378	CcSEcCtD
Vinorelbine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000378	CcSEcCtD
Vinorelbine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000376	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000126	0.00174	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000126	0.00174	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000125	0.00173	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00166	CbGpPWpGaD
Vinorelbine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000356	CcSEcCtD
Vinorelbine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000118	0.00163	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000117	0.00161	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000115	0.00159	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000113	0.00156	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000112	0.00155	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000111	0.00153	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00149	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00147	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000104	0.00143	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000103	0.00142	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9.86e-05	0.00136	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9.86e-05	0.00136	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.8e-05	0.00135	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.67e-05	0.00133	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	9.54e-05	0.00132	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	9.54e-05	0.00132	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9.52e-05	0.00131	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9.22e-05	0.00127	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	9.21e-05	0.00127	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9.02e-05	0.00124	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	8.92e-05	0.00123	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.77e-05	0.00121	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	8.72e-05	0.0012	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.22e-05	0.00113	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.22e-05	0.00113	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.18e-05	0.00113	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	8.12e-05	0.00112	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	8.09e-05	0.00112	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.06e-05	0.00111	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.94e-05	0.0011	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	7.83e-05	0.00108	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	7.79e-05	0.00107	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.71e-05	0.00106	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.69e-05	0.00106	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.62e-05	0.00105	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.62e-05	0.00105	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.52e-05	0.00104	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.51e-05	0.00104	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.41e-05	0.00102	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	7.4e-05	0.00102	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	7.16e-05	0.000988	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.12e-05	0.000983	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.03e-05	0.000969	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.75e-05	0.000931	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	6.6e-05	0.00091	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.41e-05	0.000884	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	6.34e-05	0.000874	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	6.34e-05	0.000874	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.32e-05	0.000872	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.17e-05	0.000852	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	6.12e-05	0.000844	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.08e-05	0.000839	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.06e-05	0.000835	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	5.93e-05	0.000818	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	5.8e-05	0.0008	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.73e-05	0.00079	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	5.66e-05	0.00078	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.35e-05	0.000737	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.27e-05	0.000727	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	5.21e-05	0.000718	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.91e-05	0.000678	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.85e-05	0.000668	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.76e-05	0.000657	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.66e-05	0.000642	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—chronic obstructive pulmonary disease	4.62e-05	0.000638	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.59e-05	0.000634	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.03e-05	0.000556	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.92e-05	0.000541	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.83e-05	0.000529	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.8e-05	0.000524	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.75e-05	0.000517	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.69e-05	0.000509	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.64e-05	0.000503	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.5e-05	0.000483	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.43e-05	0.000474	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.26e-05	0.000449	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.12e-05	0.000431	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.99e-05	0.000412	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.93e-05	0.000404	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.79e-05	0.000385	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.48e-05	0.000342	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.46e-05	0.000339	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.41e-05	0.000333	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.24e-05	0.00031	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.14e-05	0.000295	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.12e-05	0.000292	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.000278	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.99e-05	0.000275	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.000266	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.88e-05	0.000259	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.82e-05	0.000251	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.000245	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000231	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.000205	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.000202	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.000193	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.00019	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.000188	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.32e-05	0.000182	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.3e-05	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.000178	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000177	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000168	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000164	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000151	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.14e-06	0.000126	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.02e-06	0.000124	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	8.79e-06	0.000121	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.41e-06	0.000116	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.4e-06	0.000116	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.28e-06	0.000114	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.97e-06	0.00011	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.92e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.41e-06	7.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.18e-06	7.14e-05	CbGpPWpGaD
